Chiltern Announces New Offices and Expansion Plans in Asia Pacific
Chiltern International Limited (Chiltern), a global contract research organization (CRO), has announced its expansion plans in Asia Pacific.
Chiltern has established two new offices and launched operations in Australia and Singapore – with Singapore acting as the hub for its operations in Southeast Asia. This builds upon Chiltern’s operation in India.
Chiltern is also in the process of forming a company and establishing operations in China. Chiltern’s Asia Pacific operations will be led by Umakanta Sahoo, Executive Director, Asia Pacific. Commenting on the growth, “Chiltern’s expansion will provide a platform from which global pharmaceutical and biotech Sponsors can expand their geographic reach and enhance patient recruitment in the Asia Pacific region,” stated Dr. Sahoo.
Glenn Kerkhof, Chiltern CEO, stated, “Asia Pacific is one of the foremost emerging markets in our industry. With the current expansion of pharmaceutical R & D needs into the Asia Pacific region, Chiltern is positioned to meet the needs this growth entails. We are very pleased to provide our clients with access to this market.”
Chiltern is currently recruiting clinical staff and plans to grow its workforce in the Asia Pacific region to 70 by the end of 2010.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
